Icatibant (CED0006751)

Record Information
Version1.0
Creation Date2016-05-25 18:29:19 UTC
Update Date2026-04-14 16:03:14 UTC
Accession NumberCHEM022348
Identification
Common NameIcatibant
ClassSmall Molecule
Description
Icatibant is an organic compound with the chemical formula C59H89N19O13S. Icatibant belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 1,305 g/mol, Icatibant is a heavy molecule. The compound is found in healthcare, pharmaceuticals, and veterinary products, specifically as a hematological agent, and is administered via subcutaneous exposure. In terms of biological activity, Icatibant acts as an antagonist/inhibitor of the B2 bradykinin receptor (BDKRB2) and Aminopeptidase N (ANPEP).
Contaminant TypeNot Available
Chemical Structure
Synonyms
ValueSource
JE049HMDB
D-Arg(hyp(3)-thi(5)-D-tic(7)-oic(8))BKHMDB
HOE 140HMDB
HOE-140HMDB
Hoechst 140HMDB
Hoechst-140HMDB
Icatibant acetateHMDB
(2S)-2-({[(3as,7as)-1-{2-[(2S)-2-{[(2S)-2-{[2-({[(4R)-1-[1-(2-{[(2R)-2-amino-5-carbamimidamido-1-hydroxypentylidene]amino}-5-carbamimidamidopentanoyl)pyrrolidine-2-carbonyl]-4-hydroxypyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxyethylidene]amino}-1-hydroxy-3-(thiophen-2-yl)propylidene]amino}-3-hydroxypropanoyl]-1,2,3,4-tetrahydroisoquinoline-3-carbonyl}-octahydro-1H-indol-2-yl](hydroxy)methylidene}amino)-5-carbamimidamidopentanoateHMDB
IcatibantMeSH
Chemical FormulaC59H89N19O13S
Average Molecular Mass1304.522 g/mol
Monoisotopic Mass1303.661 g/mol
CAS Registry Number130308-48-4
IUPAC Name(2S)-2-{[(3aS,7aS)-1-{2-[(2S)-2-[(2S)-2-(2-{[(4R)-1-(1-{2-[(2R)-2-amino-5-[(diaminomethylidene)amino]pentanamido]-5-[(diaminomethylidene)amino]pentanoyl}pyrrolidine-2-carbonyl)-4-hydroxypyrrolidin-2-yl]formamido}acetamido)-3-(thiophen-2-yl)propanamido]-3-hydroxypropanoyl]-1,2,3,4-tetrahydroisoquinoline-3-carbonyl}-octahydro-1H-indol-2-yl]formamido}-5-[(diaminomethylidene)amino]pentanoic acid
Traditional Nameicatibant
SMILES[H][C@]12CC(N(C(=O)C3CC4=CC=CC=C4CN3C(=O)[C@H](CO)NC(=O)[C@H](CC3=CC=CS3)NC(=O)CNC(=O)C3C[C@@H](O)CN3C(=O)C3CCCN3C(=O)C(CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)[C@@]1([H])CCCC2)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O
InChI IdentifierInChI=1S/C59H89N19O13S/c60-37(14-5-19-67-57(61)62)48(82)72-38(15-6-20-68-58(63)64)52(86)75-22-8-18-43(75)54(88)77-30-35(80)26-44(77)50(84)70-28-47(81)71-40(27-36-13-9-23-92-36)49(83)74-41(31-79)53(87)76-29-34-12-2-1-10-32(34)24-46(76)55(89)78-42-17-4-3-11-33(42)25-45(78)51(85)73-39(56(90)91)16-7-21-69-59(65)66/h1-2,9-10,12-13,23,33,35,37-46,79-80H,3-8,11,14-22,24-31,60H2,(H,70,84)(H,71,81)(H,72,82)(H,73,85)(H,74,83)(H,90,91)(H4,61,62,67)(H4,63,64,68)(H4,65,66,69)/t33-,35+,37+,38?,39-,40-,41-,42-,43?,44?,45?,46?/m0/s1
InChI KeyQURWXBZNHXJZBE-MCDGZUPGSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentOligopeptides
Alternative Parents
Substituents
  • Alpha-oligopeptide
  • Proline or derivatives
  • N-acyl-alpha-amino acid
  • N-acyl-alpha amino acid or derivatives
  • N-acyl-l-alpha-amino acid
  • Alpha-amino acid amide
  • N-substituted-alpha-amino acid
  • Alpha-amino acid or derivatives
  • Tetrahydroisoquinoline
  • Indole or derivatives
  • N-acylpyrrolidine
  • Pyrrolidine carboxylic acid or derivatives
  • Pyrrolidine-2-carboxamide
  • Fatty acyl
  • Fatty amide
  • Benzenoid
  • N-acyl-amine
  • Thiophene
  • Heteroaromatic compound
  • Tertiary carboxylic acid amide
  • Pyrrolidine
  • Amino acid or derivatives
  • Carboxamide group
  • Guanidine
  • Amino acid
  • Secondary carboxylic acid amide
  • Secondary alcohol
  • Azacycle
  • Organic 1,3-dipolar compound
  • Carboxylic acid
  • Propargyl-type 1,3-dipolar organic compound
  • Organoheterocyclic compound
  • Monocarboxylic acid or derivatives
  • Carboximidamide
  • Primary aliphatic amine
  • Organic oxide
  • Primary amine
  • Organic nitrogen compound
  • Organic oxygen compound
  • Amine
  • Carbonyl group
  • Primary alcohol
  • Organopnictogen compound
  • Hydrocarbon derivative
  • Alcohol
  • Organonitrogen compound
  • Organooxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility0.057 g/LALOGPS
logP-2.3ALOGPS
logP-8ChemAxon
logS-4.4ALOGPS
pKa (Strongest Acidic)3.46ChemAxon
pKa (Strongest Basic)11.45ChemAxon
Physiological Charge3ChemAxon
Hydrogen Acceptor Count23ChemAxon
Hydrogen Donor Count15ChemAxon
Polar Surface Area523.72 ŲChemAxon
Rotatable Bond Count30ChemAxon
Refractivity332.91 m³·mol⁻¹ChemAxon
Polarizability137.03 ųChemAxon
Number of Rings7ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00gr-0691030200-f4034e2b8591e5c7dc90Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00fr-3950020400-0bec86946a9c590e3f8fNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0259-6930010300-8cc169eccb32d7bc5778Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0hhc-0090000000-7ca39d623eee7b68641eNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-05nf-1190000000-f36973e3c45e2e9ff484Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a6u-9520121111-b1ecb866c5afc970c045Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0w2i-0389450124-22001e497de4663bdc45Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0fe0-2246112953-7f60b7d53a3cd6d03655Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00di-9624300121-4f1f4dac936cc35dbda6Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0iml-2064520901-1a989066076a73d93a86Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001u-1091010206-19bad718402ccc5ca425Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0zfv-2094110201-f25a407e15ff561a10c2Not AvailableView Spectrum
1D NMR1H NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
1D NMR13C NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity ValuesNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
283Hematological agentsHealthcare, pharmaceuticals & veterinary productsNot Available
Pathways
1 pathway
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureB2 bradykinin receptorP25023Rattus norvegicusPredicted (SEA)0.155698
B2 bradykinin receptor structureClick to view 3D structureB2 bradykinin receptorP30411HumansPredicted (SEA)0.233548
Click to view 3D structureMu-type opioid receptorP33535Rattus norvegicusPredicted (SEA)44.6855
Delta-type opioid receptor structureClick to view 3D structureDelta-type opioid receptorP41143HumansPredicted (SEA)59.4768
Click to view 3D structureB2 bradykinin receptorO70526Cavia porcellusPredicted (SEA)0.0778492
B1 bradykinin receptor structureClick to view 3D structureB1 bradykinin receptorP46663HumansPredicted (SEA)0.544945
Click to view 3D structureB2 bradykinin receptorQ28642Oryctolagus cuniculusPredicted (SEA)0.233548
Click to view 3D structureMu-type opioid receptorP97266Cavia porcellusPredicted (SEA)161.537
Click to view 3D structureKappa-type opioid receptorP41144Cavia porcellusPredicted (SEA)140.129
Kappa-type opioid receptor structureClick to view 3D structureKappa-type opioid receptorP41145HumansPredicted (SEA)179.209
Click to view 3D structureSubstance-P receptorP14600Rattus norvegicusPredicted (SEA)77.9271
Click to view 3D structureDelta-type opioid receptorP32300Mus musculusPredicted (SEA)161.926
Click to view 3D structureDelta-type opioid receptorP33533Rattus norvegicusPredicted (SEA)148.926
Click to view 3D structureKappa-type opioid receptorP34975Rattus norvegicusPredicted (SEA)111.169
Mu-type opioid receptor structureClick to view 3D structureMu-type opioid receptorP35372HumansPredicted (SEA)256.902
Click to view 3D structureNeuropilin-1Q9QWJ9Rattus norvegicusPredicted (SEA)14.9471
Neurotensin receptor type 1 structureClick to view 3D structureNeurotensin receptor type 1P30989HumansPredicted (SEA)63.3693
Click to view 3D structureNeurotensin receptor type 2O95665HumansPredicted (SEA)53.3267
Click to view 3D structureNeurotensin receptor type 1O88319Mus musculusPredicted (SEA)60.1774
Click to view 3D structureNeuropeptide FF receptor 2Q9Y5X5HumansPredicted (SEA)122.145
Click to view 3D structureSubstance-K receptorP16610Rattus norvegicusPredicted (SEA)101.438
G-protein coupled receptor 15 structureClick to view 3D structureG-protein coupled receptor 15P49685HumansPredicted (SEA)72.4776
Click to view 3D structureMu-type opioid receptorP42866Mus musculusPredicted (SEA)145.967
Adapter molecule crk structureClick to view 3D structureAdapter molecule crkP46108HumansPredicted (SEA)78.2385
Plasminogen structureClick to view 3D structurePlasminogenP00747HumansPredicted (SEA)165.274
Concentrations
Not Available
External Links
DrugBank IDDB06196
HMDB IDHMDB0015624
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkIcatibant
Chemspider ID64461
ChEBI IDNot Available
PubChem Compound ID71364
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. Cockcroft JR, Chowienczyk PJ, Brett SE, Bender N, Ritter JM: Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist. Br J Clin Pharmacol. 1994 Oct;38(4):317-21.
2. Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W: Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol. 2007 Jun;119(6):1497-503. Epub 2007 Apr 5.